Characterization of modified antisense oligonucleotides in Xenopus laevis embryos

Oligonucleotides

Volumn 16, Issue 1, 2006, Pages 26-42

  Lennox, Kim A ^a   Sabel, Jaime L ^b   Johnson, Maegan J ^b   Moreira, Bernardo G ^a   Fletcher, Cherisa A ^a   Rose, Scott D ^a   Behlke, Mark A ^a   Laikhter, Andrei L ^a   Walder, Joseph A ^a   Dagle, John M ^a,b  

^a INTEGRATED DNA TECHNOLOGIES   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' O METHYL RNA; ANTISENSE OLIGONUCLEOTIDE; ETHYLENEDIAMINE DERIVATIVE; HETERODUPLEX; LOCKED NUCLEIC ACID; MESSENGER RNA; METHOXYETHYL PHOSPHORAMIDATE DERIVATIVE; N,N DIMETHYLETHYLENEDIAMINE; PHOSPHATE; PHOSPHODIESTER; PHOSPHORAMIDIC ACID DERIVATIVE; PHOSPHOROTHIOIC ACID DERIVATIVE; PHOSPHORUS DERIVATIVE; RNA DERIVATIVE; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASE MISPAIRING; CHEMICAL MODIFICATION; CHIMERA; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SAFETY; DRUG SPECIFICITY; DRUG SYNTHESIS; DRUG TARGETING; EMBRYO; GENE EXPRESSION; GENE TARGETING; MELTING POINT; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA DEGRADATION; XENOPUS LAEVIS;

AMIDES; ANIMALS; BASE PAIR MISMATCH; BASE SEQUENCE; DEOXYRIBONUCLEASES; EMBRYO, NONMAMMALIAN; ETHYLENEDIAMINES; GENE EXPRESSION; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORIC ACIDS; RNA, MESSENGER; TEMPERATURE; XENOPUS LAEVIS; XENOPUS PROTEINS;

ANIMALIA; XENOPUS LAEVIS;

EID: 33645817932     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2006.16.26     Document Type: Article

References (45)

1. BISBEE, C.A., BAKER, M.A., WILSON, A.C., HAJI-AZIMI, I., and FISCHBERG, M. (1977). Albumin phylogeny for clawed frogs (Xenopus). Science 195, 785-787.
2. BONHAM, M.A., BROWN, S., BOYD, A.L., BROWN, P.H., BRUCKENSTEIN, D.A., HANVEY, J.C., TOMSON, S.A., PIPE, A., HASSMAN, F., BISI, J.E., FROEHLER, B.C., MATEUCCI, M.D., WAGNER, R.W., NOBLE, S.A., and BABISS, L.E. (1995). An assessment of the antisense properties of RNase H competent and steric-blocking agents. Nucleic Acids Res. 23, 1197-1203.
3. CHIANG, M.Y., CHAN, H., ZOUNES, M.A., FREIER, S.M., LIMA, W.F., and BENNETT, C.F. (1991). Antisense oligonucleotides inhibit intercellular adhesion molecule I expression by two distinct mechanisms. J. Biol. Chem. 266, 18162-18171.
4. CHOI, S.C., and HAN, J.K. (2005). Rap2 is required for Wnt/beta-cateinin signaling pathway in Xenopus early development. EMBO J. 24, 985-996.
5. DAGLE, J.M., ANDRACKI, M.E., DEVINE, R.J., and WALDER, J.A. (1991a). Physical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages. Nucleic Acids Res. 19, 1805-1810.
6. DAGLE, J.M., LITTIG, J.L., SUTHERLAND, L.M., and WEEKS, D.L. (2000). Targeted elimination of zygotic messages in Xenopus laevis embryos by modified oligonucleotides possessing terminal cationic linkages. Nucleic Acids Res. 28, 2153-2157.
7. DAGLE, J.M., SABEL, J.L., LITTIG, J.L., SUTHERLAND, L.M., KOLKER, S.J., and WEEKS, D.L. (2003). Pitx2c attenuation results in cardiac defects and abnormalities of intestinal orientation in developing Xenopus laevis. Dev. Biol. 262, 268-281.
8. DAGLE, J.M., WALDER, J.A., and WEEKS, D.L. (1990). Targeted degradation of mRNA in Xenopus oocytes and embryos directed by modified oligonucleotides: Studies of An 2 and cyclin in embryogenesis. Nucleic Acids Res. 18, 4751-4757.
9. DAGLE, J.M., WEEKS, D.L., and WALDER, J.A. (1991b). Pathways of degradation and mechanism of action of antisense oligonucleotides in Xenopus laevis embryos. Antisense Res. Dev. 1, 11-20.
10. FISHER, T.L., TERHORST, T., CAO, X., and WAGNER, R.W. (1993). Intracellular disposition and metabolism of fluorescently labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acids Res. 21, 3857-3865.
11. FREIER, S.M., and ALTMANN, K.H. (1997). The ups and downs of synthetic nucleic acid duplex stability: Structure-stability studies on chemically modified DNA:RNA duplexes. Nucleic Acids Res. 25, 4429-4443.
12. FRIEDEN, M., CHRISTENSEN, S.M., MIKKELSEN, N.D., ROSENBOHM, C., THRUE, C.A., WESTERGAARD, M., HANSEN, H.F., ØRUM, H., and KOCH, T. (2003). Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA. Nucleic Acids Res. 31, 6365-6372.
13. GRUNWELLER, A., WYSZK, B., BIEBER, B., JAHNEL, R., ERDMANN, V.A., and KURRECK, J. (2003). Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methl RNA, phosphorothioates, and small interfering RNA. Nucleic Acids Res. 31, 3185-3193.
14. GUTTIERREZ, A.J., MATTEUCCI, M.D., GRANT, D., MATSUMURA, S., WAGNER, R.W., and FROEHLER, B.C. (1997). Antisense gene inhibition by C-5 substituted deoxyuridine-containing oligodeoxynucleotides. Biochemistry 36, 743-748.
15. HANVEY, J.C., PEFFER, J.N., BISI, J.E., THOMSON, S.A., CADILLA, R., JOSEY, J.A., RICCA, D.J., HASSMAN, C.F., BONHAM, M.A., AU, K.G. CARTER, S.G., BRUCKENSTEIN, D.A., BOYD, A.L., NOBLE, S.A., and BABISS, L.E. (1992). Antisense and antigene properties of peptide nucleic acids. Science 258, 1481-1485.
16. HEASMAN, J., GINSBERG, D., GEIGER, B., GOLDSTONE, K., PRATT, T., YOSHIDA-NORO, C., and WYLIE, C. (1994). A functional test for maternally inherited cadherin in Xenopus shows its importance in cell adhesion at the blastula stage. Development 120, 49-57.
17. HEIDENREICH, O., GRYAZNOV, S., and NERENBERG, M. (1997). RNase H-independent antisense activity of oligonucleotide N3′-P5′ phosphoramidates. Nucleic Acids Res. 25, 776-780.
18. INOUE, H., HAYASE, Y., IWAI, S., and OHTSUKA, E. (1987). Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Left. 2, 327-330.
19. IYER, R.P., PHILLIPS, L.R., EGAN, W., REGAN, J.B., and BEAUCAGE, S.L. (1990). The automated synthesis of sulfur-containing oligodeoxyribonucleotides using 3H-1,2-benzohithiol-3-one 1,1-dioxide as a sulfur-transfer. J. Org. Chem. 55, 4693-4699.
20. JOHANSSON, H.E., BELSHAM, G.J., SPROAT, B.S., and HENTZE, M.W. (1994). Target-specific arrest of mRNA translation by antisense 2′-O-alkyl oligoribonucleotides. Nucleic Acids Res. 22, 4591-4598.
21. KURRECK, J., WYSZKO, E., GILLEN, C., and ERDMANN, V.A. (2002). Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 30, 1911-1918.
22. LOK, C.N., VIAZOVKINA, E., MIN, K.L., NAGY, E., WILDS, C.J., DAMHA, M.J., and PARNIAK, M.A. (2002). Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2′-deoxy-2′- fluoro-D-arabinose and 2′-deoxyribose nucleotides. Biochemistry 41, 3457-3467.
23. MILLER, P.S., AGRIS, C.H., AURELIAN, L., BLAKE, K.R., MURAKAMI, A., REDDY, M.P., SPITZ, S.A., and TS'O, P.O. (1985). Control of ribonucleic acid function by oligonucleoside methylphosphonates. Biochime 67, 769-776.
24. MONIA, B.P., JOHNSTON, J.F., GEIGER, T., MULLER, M., and FABBRO, D. (1996). Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat. Med. 2, 668-675.
25. MONIA, B.P., LESNIK, E.A., GONZALEZ, C., LIMA, W.F., McGEE, D., GUINOSSO, C.J., KAWASAKI, A.M., COOK, P.D., and FREIER, S.M. (1993). Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268, 14514-14522.
26. MORENO, M., MUNOZ, R., AROCA, F., LABARCA, M., BRANDAN, E., and LARRAIN, J. (2005). Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. EMBO J. 24, 1397-1405.
27. MURPHY, C.R., SABEL, J.L., SANDLER, A.D., and DAGLE, J.M. (2002). Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis. Dev. Dyn. 225, 597-601.
28. NEWPORT, J., and KIRSCHNER, M. (1982). A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription. Cell 30, 687-696.
29. NIELSEN, P.E. (1995). DNA analogues with nonphosphodiester backbones. Annu. Rev. Biophys. Biomol. Struct. 24, 167-183.
30. OWCZARZY, R., YOU, Y., MOREIRA, B.G., MANTHEY J.A., HUANG, L., BEHLKE, M.A., and WALDER, I.A. (2004). Effects of sodium ions on DNA duplex oligomers: Improved predictions of melting temperatures. Biochemistry 43, 3537-3554.
31. RAIT, V.K., and SHAW, B.R. (1999). Boranophosphates support the RNase H cleavage of polyribonucleotides. Antisense Nucleic Acid Drug Dev. 9, 53-60.
32. REBAGLIATI, M.R., WEEKS, D.L., HARVEY, R.P., and MELTON, D.A. (1985). Identification and cloning of localized maternal RNAs from Xenopus eggs. Cell 42, 769-777.
33. SHEEHAN, D., LUNSTAD, B., YAMADA, C.M., STELL, E.G., CARUTHERS, M.H., and DELLINGER, D.I. (2003). Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides. Nucleic Acids Res. 31, 4109-4118.
34. SHEN, Z.I., KIM, S.K., KWON, O.S., LEE, Y.S., and MOON, B.J. (2001). Specific inhibition of transforming growth factor-beta2 expression in human osteoblast cells by antisense phosphorothioate oligonucleotides. Eur. J. Biochem. 268, 2331-2337.
35. SHIBARHARA, S., MUKAI, S., NISHIHARA, T., INOUE, H., OBHSUKA, E., and MORISAWA, H. (1987). Site-directed cleavage of RNA. Nucleic Acids Res. 15, 4403-4415.
36. SORENSEN, M.D., KVAERNO, L., BRYLD, T., HAKANSSON, A.E., VERBEURE, B., GAUBERT, G., HERDEWIJN, P., and WENGEL, J. (2002). α-L-ribo-Configured locked nucleic acid (α-L-LNA): Synthesis and properties. J. Am. Chem. Soc. 124, 2164-2176.
37. SPROAT, B.S., LAMOND, A.I., BEIJER, B., NEUNER, P., and RYDER, U. (1989). Highly efficient chemical synthesis of 2′-O-methyl oligoribonucleotides and tetrabiotinylated derivatives: Novel probes that are resistant to degradation by RNA or DNA specific nucleases. Nucleic Acids Res. 17, 3373-3386.
38. STEIN, C.A. (1996). Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity. Trends Biotechnol. 14, 147-149.
39. STEIN, D., FOSTER, E., HUANG, S.B., WELLER, D., and SUMMERTON, J.A. (1997). A specificity comparison of four antisense types: Morpholino, 2′-O-methyl RNA, DNA, and phosphorothioate DNA. Nucleic Acid Drug Dev. 7, 151-157.
40. STEPHENSON, M.L, and ZAMECNIK, P.C. (1978). Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. USA 75, 285-282.
41. SUMMERTON, J., and WELLER, D. (1997). Morpholino antisense oligomers: Design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 7, 187-195.
42. VEENSTRA, G.J.C., WEEKS, D.L., and WOLFFEE, A.P. (2000). Distinct roles for TBP and TBP-like factor in early embryonic gene transcription in Xenopus. Science 290, 2312-2315.
43. WAHLESTEDT, C., SALMI, P., GOOD, L., KELA, J., JOHNSSON, T., HOKFELT, T., BROGERGER, C., PORRECA, F., LAI, J., REN, K., OSSIPOV, M., KOSHKIN, A., JAKOBSEN, N., SKOUV, J., OERUM, H., JACOBSEN, M.H., and WENGEL, J. (2000). Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl. Acad. Sci. USA 97, 5633-5638.
44. WALDER, R.Y., and WALDER, L.A. (1988). Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 85, 5011-5015.
45. WEEKS, D.L,. WALDER, J.A., and DAGLE, J.M. (1991). Cyclin B mRNA depletion only transiently inhibits the Xenopus embryonic cell cycle. Development 111, 1173-1178.